As verified in a relatively large cohort (a total of 74 patients), FOXP1 was found to be downregulated in ICC tissues, and negative FOXP1 expression is an independent prognostic risk factor for OS. This evidence concerns the gene FOXP1 and intrahepatic cholangiocarcinoma.